Befolkningsfarmakokinetisk evaluering har ikke vist tegn på klinisk signifikante racerelaterede forskelle eller at rygning skulle påvirke farmakokinetik for aripiprazol.
Population pharmacokinetic evaluation has revealed no evidence of clinically significant race-related differences or effects from smoking upon the pharmacokinetics of aripiprazole.